Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Fulda
Clinical trial register · Germany

Clinical Trials in Fulda, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5081 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5081
Studies in scope
all four open statuses
2880
Recruiting now
open to new participants
985
Lead sponsors
across recruiting studies
Top sites
Berlin 1591 Hamburg 896 Essen 767 Dresden 717 Heidelberg 626

Trials with a site in Fulda

10 of 5081 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Bonn, Coswig, Essen, Freiburg im Breisgau, Fulda, Giessen, Hamburg, Hanover
2026-06-11
Active, closed
Novo Nordisk A/S
Phase 3
985
Bad Oeynhausen, Elsterwerda, Essen, Fulda, Hamburg, Lingen, Magdeburg, Osnabrück
2026-05-20
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Bad Oeynhausen, Elsterwerda, Fulda, Magdeburg, Osnabrück, Witten
2026-02-24
Active, closed
Novo Nordisk A/S
Observational
245
Pirna, Bramsche, Bünde, Dortmund, Duisburg, Fulda, Herne, Hof
2025-08-28
Recruiting
Bial - Portela C S.A.
Observational
90
Berlin, Bochum, Freiburg im Breisgau, Fulda, Hetzdorf, Osnabrück, Siegen, Sundern
2025-08-27
Recruiting
AbbVie
Phase 2
590
Freiburg im Breisgau, Mannheim, Ulm, Erlangen, Munich, Regensburg, Frankfurt am Main, Fulda
2024-09-04
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Active, closed
Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis
NCT03843385Ulcerative Colitis, Inflammatory Bowel Diseases
Andreas Stallmach
Phase 3
84
Jena, Bamberg, Berlin, Dresden, Erlangen, Frankfurt, Freiburg im Breisgau, Fulda
2023-01-31
Active, closed
Sanofi
Phase 2
187
Düsseldorf, Fulda, Kiel, Ludwigshafen, Ulm
2022-11-25
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Berlin, Dresden, Erlangen, Frankfurt, Frankfurt am Main, Freiburg im Breisgau, Fulda, Halle
2022-09-19
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-germany/city/fulda

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,081 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Fulda.

How many clinical trials are recruiting in Fulda?

4 of the 10 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fulda), 10 studies
PhaseStudiesRecruitingShare
Phase 24240%
Phase 34140%
Observational2120%

Most active sponsors

Lead sponsors with the most studies (Fulda)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S41
AbbVie11
Andreas Stallmach10
AstraZeneca11
Bial - Portela C S.A.11
Janssen Research & Development, LLC10
Sanofi10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.